Neuro-Oncology Advances
Country
United Kingdom
Western Europe
Subject Area and Category
Medicine
└
Neurology (clinical)
Q1
└
Oncology
Q1
└
Surgery
Q1
Publisher
SJR 2025
1.421
Q1
SJR Score
H-Index
42
Citations / Doc (2yr)
4.02
Total Docs. (latest)
227
Total Citations (3yr)
2,238
Publication type
Journals
ISSN
26322498
Coverage
2019-2026
Journal Rank
#2,675
Subject Categories
Neurology (clinical)
Q1
Oncology
Q1
Surgery
Q1
Subject Areas
Aims & Scope
1.
High-quality research on primary brain malignancies, noting that studies with negative outcomes are also valuable for the field and confirmatory studies are increasingly important.
2.
Brain metastases, cancer-related neurological events and advances in management of brain metastases and cancer in general to prevent brain metastases.
3.
Non-malignant nervous system tumors including meningiomas, schwannomas, pituitary tumors, spinal and peripheral nerve tumors.
4.
Technological advances in surgery, radiation therapy, radiosurgery and imaging
5.
Bioinformatics and computational advances in large data analyses related to subjects within our scope.
6.
Spinal tumors and spine metastases.
Abstracting & Indexing
Scopus
Google Scholar
Directory of Open Access Journals (DOAJ)
Web of Science
Embase
Detailed Metrics
| Total Docs. (latest) | 227 |
| Total Docs. (3 years) | 551 |
| Total Refs. | 10,793 |
| Total Citations (3 years) | 2,238 |
| Citable Docs. (3 years) | 538 |
| Citations / Doc. (2 years) | 4.02 |
| Ref. / Doc. | 47.55 |
| % Female | 40.1% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Frequently Asked Questions
What is the impact factor of Neuro-Oncology Advances?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Neuro-Oncology Advances has an SJR of 1.421 and is ranked Q1.
What is the SJR and quartile of Neuro-Oncology Advances?
Neuro-Oncology Advances has an SJR (SCImago Journal Rank) of 1.421 and its best quartile is Q1.
What is the H-index of Neuro-Oncology Advances?
The H-index of Neuro-Oncology Advances is 42, meaning 42 of its articles have each been cited at least 42 times.
Is Neuro-Oncology Advances indexed in Scopus?
Yes. Neuro-Oncology Advances is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.